Toshiyuki Yoneda — Indiana University School of Medicine

Area of research

Oncology · Molecular Biology

Research interest

Research interests include Denosumab, Medicine, Placebo, Rheumatoid arthritis, Clinical endpoint, and Internal medicine.

Recent publications

Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial

Annals of the Rheumatic Diseases 2019cited by 136position: middledoi

Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial

Annals of the Rheumatic Diseases 2016cited by 162position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tsutomu Takeuchi · Keio University2 papers (2016–2019)— · 2 papers (2016–2019)Désirée van der Heijde · Leiden University2 papers (2016–2019)Yoshiya Tanaka · Chukyo Hospital2 papers (2016–2019)Harry K. Genant · University of California, San Francisco2 papers (2016–2019)Hisashi Yamanaka · Sanno Medical Center2 papers (2016–2019)— · 1 papers (2019–2019)Naoki Ishiguro · Aichi Developmental Disability Center1 papers (2016–2016)— · 1 papers (2019–2019)Sakae Tanaka · Saitama Medical University1 papers (2019–2019)— · 1 papers (2016–2016)

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Oncology · Molecular Biology →